跳至主要内容
临床试验/NCT04362384
NCT04362384Unknown3 期

Topical Endorectal Vietamin E Ovules for the Treatment of Grade 2 and 3 Hemorrhoids

Hospital General Universitario Elche0 个研究点目标入组 120 人开始时间: 2020年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
120
主要终点
% of patients with Bleeding

研究概览

简要总结

Patients with hemorrohoids grade II and III were included. Patients were randomized into 2 groups:

  • Experimental group: Patients will receive a treatment with vitamin E ovules, which must be placed inside the annus
  • Control group: Patients will receive a treatment with corticoid ointment, with endoanal application

Bleeding, pain and stinging will be evaluated 14 days after beginning the treatment.

详细描述

Patients with hemorrohoids grade II and III were included.

Patients were randomized into 2 groups:

  • Experimental group: Patients will receive a treatment with vitamin E ovules, which must be placed inside the annus. 1 ovule must be inserted daily during 14 days.
  • Control group: Patients will receive a treatment with prednisolone ointment, with endoanal application 3 times per day during 14 days.

Bleeding, pain and stinging will be evaluated 14 days after beginning the treatment. Quantification of pain will be performed following a visual analogic scale ranging from 0 (absence of symptoms) to 100 (unbearable symptoms).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Symptoms will be assessed by a nurse blinded to the prescribed treatment

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Grade II and III hemorrhoids

排除标准

  • Grade I or IV hemorrhoids
  • Patients with previous anal surgeries
  • Patients having received previous pharmacological treatments for hemorrhoids

研究组 & 干预措施

Vitamin E ovules

Experimental

Endoanal Vitamin E ovules will be prescriped during 14 days

干预措施: Vitamin E ovules (Drug)

Prednisolone ointment

Active Comparator

Endoanal Prednisolone ointment will be prescriped during 14 days

干预措施: Prednisolone ointment (Drug)

结局指标

主要结局

% of patients with Bleeding

时间窗: 14 days after beginning the treatment

The patient refers rectal bleeding during defecation (patients´self-report) or active bleeding is observed at rectal examination. The variable will be measured as present (1) or absent(0)

次要结局

  • Anal pain assessed by Visual Analogic Scale(14 days after beginning the treatment)
  • % of patients with Stinging(14 days after beginning the treatment)

研究者

发起方
Hospital General Universitario Elche
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jaime Ruiz-Tovar, MD, PhD

Department of Surgery

Hospital General Universitario Elche

相似试验

Topical Vitamin E Ovules for the Treatment of... | 临床试验